The ENDS 2019 Advisory Board worked together with Smithers Rapra to produce a balanced and informative programme, that covered the most important ENDS-related topics.
See below for more information about the 2019 Advisory Board members.
John Dunne is currently the Managing Director of E-liquid Brands based in London . E-Liquid Brands is a manufacturer and distributor of premium UK and US e-liquids who’s brands include Ohmbrew, DripWich, Squeezee , Snodrone and Wanderlust.
John has a strong background and reputation in the European Electronic cigarette industry having held senior executive positions in some of Europe’s biggest companies, and advises many leading industry analysists, financial institutions and media organizations looking at the vaping category.
Ian is an independent consultant with expertise in regulatory and scientific aspects of nicotine and tobacco products. Ian most recently worked for JUUL Labs as Senior Director of Clinical and Regulatory Affairs EMEA, and previously he was Director of Tobacco Research at Celerion, a provider of clinical research capabilities and expertise to the tobacco and e-cigarette industry. Prior to that, Ian was Principal Scientist and Head of Clinical Research at British American Tobacco's central research and development centre in Southampton, U.K. He specializes in the biological and psychological effects of nicotine, clinical and pre-clinical studies to assess the biological effects of electronic cigarettes and tobacco heating devices, and the scientific basis for regulation. Prior to working in the industry, Ian pursued an academic career as a Lecturer in Physiology at the University of Manchester and an Assistant Professor in Biology at McMaster University in Hamilton, Canada. Ian is a highly-cited scientific researcher and writer, contributing to more than 50 peer-reviewed papers and book chapters which have generated over 2,400 citations.
Andrew Feilden joined Smithers Rapra as a Principal Consultant in June 2011 and was appointed Chemistry Operations Director in October 2012. He specializes in extractable and leachable testing and the selection and assessment of materials for medical and pharmaceutical applications. Andrew previously worked at AstraZeneca for 12 years, leading their extractable and leachable testing. He has been working in the field of trace analysis using hyphenated techniques such as GC-MS and LC-MS for over 12 years. Whilst at AstraZeneca he was an active member of industry working groups, the IPAC-RS container closure group and he was the co-chair of ELSIE material group. Andrew gained a degree and D.Phil from York University.
Scott is the Director of Analytical Services at Crawford Scientific where he heads up their specialist MS based laboratory, Hall Analytical, in Manchester, UK.
Hall Analytical has a long association with e-cigarette analysis and development with over 10 years experience of preforming analytical testing on the very early cigalike prototypes.
Before this he spent many years working as a professional trainer and consultant in analytical chemistry and prior to that he worked in the pharmaceutical industry in the incredibly analogous field of developing dry powder inhalers!
Scott sits on the Separation Science Committee of the Royal Society of Chemistry, of whom he is a Fellow, and on the Editorial Advisory Board of various Separation Science publications and is regular speaker at national and internal conferences.
Liam Humberstone is Technical Director at Totally Wicked Limited. His involvement with standards and regulations for e-cigarettes and e-liquid started with a notorious legal challenge, but he has since worked collaboratively with regulators at UK National, European and other International levels. His background is in design engineering and scientific research, and he has been involved in the e-cigarette industry since 2011.
A global legal and compliance industry expert Patricia I. Kovacevic’s experience comprises general counsel and chief compliance officer roles at Nicopure Labs LLC, and leading senior legal and compliance positions at, among others, Philip Morris International and Lorillard. Prior to joining Lorillard she was a partner at Patton Boggs. Her expertise includes global e-cigarette and tobacco regulation, compliance and all regulatory aspects of marketing/media communications, corporate affairs, criminal investigations, FCPA, trade sanctions, privacy, product development and launch. Kovacevic served on the board of directors of the Vapor Technology Association and on the advisory board of the Global Tobacco & Nicotine Forum. In the past she was a United Nations staff member, served on the U.N.’s Public-Private Partnership Commission and was also an adviser to the Council for Burley Tobacco. Kovacevic is admitted to practice in New York and before the Supreme Court of the United States. She holds a J.D. from Columbia Law School in New York and has completed the Harvard Business School “Corporate Leader” course. She is fluent in seven European languages.
Ian Tindall is the Innovation and Marketing Director of Cerulean, a respected manufacturer of laboratory test equipment for the vaping industry. Ian is responsible for defining the new products that Cerulean brings to market and has been instrumental in expanding the Cerulean portfolio to ENDS testing. His working life has been concerned with the design of scientific and industrial instrumentation, firstly for VG Scientific then for Zellweger Analytics (now part of Honeywell) before joining Cerulean in 2004. He has presented scientific papers at CORESTA, TSRC and ACS on subjects concerned with tobacco testing. He has had numerous articles published in trade journals and holds patents in topics as diverse as x-ray source design and electrodes for gas detection. Ian graduated from the University of Manchester Institute of Science and Technology with a degree in Analytical Chemistry and has a PhD in Physical Chemistry from Manchester University in the UK.